Urol. praxi. 2024;25(4):205-209 | DOI: 10.36290/uro.2024.072

Multidisciplinary approach in the diagnosis and therapy of renal tumours

MUDr. Jindřich Kopecký, Ph.D.1, MUDr. Jiří ©paček2, MUDr. Petr Hoffmann, Ph.D.3, MUDr. Miroslav Podhola, Ph.D.4, MUDr. Peter Priester1, MUDr. Alľbeta Hlodáková5
1 Klinika onkologie a radioterapie, LF a FN Hradec Králové
2 Urologická klinika, LF a FN Hradec Králové
3 Radiologická Klinika, LF a FN Hradec Králové
4 Fingerlandův patologický ústav, LF a FN Hradec Králové
5 Onkologická klinika, FN Královské Vinohrady, Praha

This review article provides a comprehensive view of diagnostics of renal tumours from perspective of different disciplines involved in the diagnosis and treatment of renal tumours (urologists, clinical oncologists, radiologists and pathologists). Diagnostic strategies, treatment options, and the importance of a multidisciplinary team to optimize treatment outcomes for patients with renal tumors outside the renal pelvis are discussed.

Keywords: renal tumor, diagnostics, multidisciplinary team, therapy.

Accepted: November 11, 2024; Published: November 25, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kopecký J, ©paček J, Hoffmann P, Podhola M, Priester P, Hlodáková A. Multidisciplinary approach in the diagnosis and therapy of renal tumours. Urol. praxi. 2024;25(4):205-209. doi: 10.36290/uro.2024.072.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • PDF will be unlocked 25.11.2025

    References

    1. Hollingsworth JM, Miller DC, Daignault S, et al. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst. 2006;98(18):1331-1334. Go to original source... Go to PubMed...
    2. Bukavina L, Bensalah K, Bray F, et al. Epidemiology of Renal Cell Carcinoma: 2022 Update. Eur Urol. 2022;82(5):529-542. Go to original source... Go to PubMed...
    3. Cheaib JG, Patel HD, Johnson MH, et al. Stage-specific conditional survival in renal cell carcinoma after nephrectomy. Urol Oncol. 2020;38(1):6.e1-6.e7. Go to original source... Go to PubMed...
    4. Ali RM, Muhealdeen DN, Fakhralddin SS, et al. Prognostic factors in renal cell carcinoma: a single‑center study. Mol Clin Oncol. 2023;19(3):66. Go to original source... Go to PubMed...
    5. Bahadoram S, Davoodi M, Hassanzadeh S, et al. Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment. G Ital Nefrol. 2022;39(3).
    6. Dhanji S, Wang L, Liu F, et al. Recent Advances in the Mana­gement of Localized and Locally Advanced Renal Cell Carcinoma: A Narrative Review. Res Rep Urol. 2023;15:99-108. Go to original source... Go to PubMed...
    7. Singla N, Hutchinson RC, Ghandour RA, et al. Improved survival after cytoreductive nephrectomy for metastatic renal cell carcinoma in the contemporary immunotherapy era: an analysis of the National Cancer Database. Urol Oncol. 2020;38(6):604.e9-604.e17. Go to original source... Go to PubMed...
    8. Umbreit EC, Shimko MS, Childs MA, et al. Metastatic potential of a renal mass according to original tumour size at presentation. BJU Int. 2012;109(2):190-194; discussion 194. Go to original source... Go to PubMed...
    9. Thompson RH, Hill JR, Babayev Y, et al. Metastatic renal cell carcinoma risk according to tumor size. J Urol. 2009;182(1): 41-45. Go to original source... Go to PubMed...
    10. Monda SM, Lui HT, Pratsinis MA, et al. The Metastatic Risk of Renal Cell Carcinoma by Primary Tumor Size and Subtype. Eur Urol Open Sci. 2023;52:137-144. Go to original source... Go to PubMed...
    11. Remzi M, Ozsoy M, Klingler HC, et al. Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter. J Urol. 2006;176(3):896-899. Go to original source... Go to PubMed...
    12. Ramanathan R, Leveillee RJ. Ablative therapies for renal tumors. Ther Adv Urol. 2010;2(2):51-68. Go to original source... Go to PubMed...
    13. Kunkle DA, Uzzo RG. Cryoablation or radiofrequency ablation of the small renal mass: a meta-analysis. Cancer. 2008;113(10):2671-2680. Go to original source... Go to PubMed...
    14. Mickisch GH, Garin A, van Poppel H, et al. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet. 2001; 358(9286): 966-970. Go to original source... Go to PubMed...
    15. Flanigan RC, Salmon SE, Blumenstein BA, et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med. 2001;345(23):1655-1659. Go to original source... Go to PubMed...
    16. Bex A, Mulders P, Jewett M, et al. Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial. JAMA Oncol. 2019;5(2):164-170. Go to original source... Go to PubMed...
    17. Méjean A, Ravaud A, Thezenas S, et al. Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma. N Engl J Med. 2018;379(5):417-427. Go to original source... Go to PubMed...
    18. Studentova H, Spisarova M, Kopova A, et al. The Evolving Landscape of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma. Cancers. 2023;15(15):3855. Go to original source... Go to PubMed...
    19. Morshid A, Duran ES, Choi WJ, et al. A Concise Review of the Multimodality Imaging Features of Renal Cell Carcinoma. Cureus. 2021;13(2):e13231. Go to original source... Go to PubMed...
    20. Wang HY, Ding HJ, Chen JH, et al. Meta-analysis of the diagnostic performance of [18F]FDG-PET and PET/CT in renal cell carcinoma. Cancer Imaging. 2012;12(3):464-474. Go to original source... Go to PubMed...
    21. Silverman SG, Pedrosa I, Ellis JH, et al. Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment. Radiology. 2019;292(2):475-488. Go to original source... Go to PubMed...
    22. Matar S, El Ahmar N, Laimon YN, et al. The Role of the Pathologist in Renal Cell Carcinoma Management. Hematol Oncol Clin North Am. 2023;37(5):849-862. Go to original source... Go to PubMed...
    23. Ricketts CJ, Linehan WM. Intratumoral heterogeneity in kidney cancer. Nat Genet. 2014;46(3):214-215. Go to original source... Go to PubMed...
    24. Beksac AT, Paulucci DJ, Blum KA, et al. Heterogeneity in renal cell carcinoma. Urol Oncol. 2017;35(8): 507-515. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.